Core 1: Administration
Core 1: Administration
批准号:
10631158
负责人:
HAIAN FU
金额:
$15.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-01 至 2027-05-31
关键词:
AdvocateAwardBasic Cancer ResearchBioinformaticsBiologyBiostatistics CoreCancer CenterClinical InvestigatorClinical TrialsCollaborationsCommunicationConsultationsDataDecision MakingEnsureEthicsEvaluationEvaluation ResearchFundingFutureGoalsGrantHuman ResourcesImmunotherapyIndividualInstitutionInterdisciplinary StudyLeadershipLung AdenocarcinomaMaintenanceMalignant neoplasm of lungMonitorNational Cancer InstituteOffice of Administrative ManagementPatientsPerformancePoliciesPreparationProceduresProductivityProgram Research Project GrantsProgress ReportsQuality ControlRecommendationRegulationReportingResearchResistanceResource SharingResourcesSTK11 geneScheduleScienceStrategic PlanningTherapeuticTrainingTranslatingUnited States National Institutes of HealthUniversitiesclinical translationdata qualityexperienceexperimental studyimprovedinterdisciplinary approachlecturesmeetingsmemberoperationprogramsquality assurancerecruitremediationsuccesssymposium
中文摘要
总结
对于肺癌P01的成功至关重要,管理核心的总体目标是提供
领导和协调所有科学活动,以及财政管理和一般行政管理
活动,以最大限度地提高埃默里大学肺癌P01的综合性能。的
行政核心将由Haian Fu博士,Suresh Ramalingam博士和Adam Marcus博士领导,
在成功和富有成效的管理个人和大型多,
学科研究计划结合了基础研究癌症药理学家的观点,
翻译临床研究者和LKB 1生物学专家,以简化和确保高质量
P01的决策。
行政核心将提供三个不同的具体职能:(1)行政(2)协调(3)
监测和执行。行政职能将包括监督所有项目和核心活动,
财政监督、提供必要的资源、获得和分配机构支助,
编写年度进展报告和其他文件。协调职能将包括规划和
每月计划会议和定期咨询委员会会议的安排,咨询委员会的参与
成员包括患者倡导者,协调项目、核心和
P01和癌症中心,与NCI项目官员和工作人员的沟通和协商,组织
P01主办的讲座和研讨会。监测和执行工作将包括定期跟踪和
评估所有项目和核心的研究进展和数据质量,
建议,补救表现不佳的项目,并确保遵守所有政府,
NCI以及当地法规和要求。
在P01执行委员会的指导下,执行委员会由计划、项目和核心领导人组成,
在咨询委员会的参与下,行政核心将促进方案内的合作,
整合项目和核心,以形成统一的多学科方法,重点是利用我们的
提高对肺腺癌中LKB 1相关免疫治疗耐药性的认识,
将这些研究转化为当前和未来的治疗机会。
英文摘要
SUMMARY
Vital to the success of the Lung Cancer P01, the overall goal of the Administrative Core is to provide
leadership and coordination of all scientific activities, as well as fiscal management and general administrative
activities in order to maximize the integrated performance of the Emory University Lung Cancer P01. The
Administrative Core will be led by Drs. Haian Fu, Suresh Ramalingam and Adam Marcus, whose varied
experience and expertise in the successful and productive management of individual and large multi-
disciplinary research programs combines the perspectives of a basic research cancer pharmacologist with a
translational clinical investigator and an expert in LKB1 biology in order to streamline and ensure high-quality
decision-making for the P01.
The Administrative Core will provide three distinct specific functions: (1) administration (2) coordination (3)
monitoring and implementation. Administrative functions will include oversight of all Project and Core activities,
fiscal oversight, provision of the necessary resources, acquisition and allocation of institutional support,
preparation of annual progress reports and other documents. Coordination functions will include planning and
scheduling of monthly program meetings and regular advisory board meetings, engagement of advisory board
members including patient advocates, coordination of interactions between Projects, Cores and between the
P01 and the Cancer Center, communication and consultation with NCI project officer and staff, organization of
P01-sponsored lectures and symposia. Monitoring and implementation will include regular tracking and
evaluation of research progress and data quality for all projects and cores, implementation of advisors’
recommendations, remediation of under-performing projects, and assuring compliance with all governmental,
NCI, and local regulations and requirements.
Guided by the P01 Executive Committee, comprised of Program, Project and Core leaders, as well as
engaged advisory boards, the Administrative Core will facilitate intra-programmatic collaborations and
integration of the projects and cores to result in a unified multidisciplinary approach focused on exploiting our
improved understanding of LKB1-associated immunotherapy resistance in lung adenocarcinoma and
translating these studies into current and future therapeutic opportunities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Administration
-
批准号:10411669
-
项目类别:
-
资助金额:$16.68万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
-
批准号:10411665
-
项目类别:
-
资助金额:$222.93万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
-
批准号:10631134
-
项目类别:
-
资助金额:$216.48万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
-
批准号:10631142
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
-
批准号:10411667
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:10685410
-
项目类别:
-
资助金额:$183.99万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:10210194
-
项目类别:
-
资助金额:$182.51万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Developmental Research Program
-
批准号:10685427
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Developmental Research Program
-
批准号:10210204
-
项目类别:
-
资助金额:$8.98万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:10459437
-
项目类别:
-
资助金额:$183.99万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:9975749
-
项目类别:
-
资助金额:$186.51万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Developmental Research Program
-
批准号:10459443
-
项目类别:
-
资助金额:$9.7万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
-
批准号:10210364
-
项目类别:
-
资助金额:$93.24万
-
财政年份:2017
-
负责人:HAIAN FU
-
依托单位:
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
-
批准号:9752497
-
项目类别:
-
资助金额:$90.5万
-
财政年份:2017
-
负责人:HAIAN FU
-
依托单位:
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
-
批准号:9363451
-
项目类别:
-
资助金额:$79.13万
-
财政年份:2017
-
负责人:HAIAN FU
-
依托单位:
High Throughput Protein-Protein Interaction Interrogation in Cancer
-
批准号:8660662
-
项目类别:
-
资助金额:$83.43万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER
-
批准号:8561414
-
项目类别:
-
资助金额:$82.6万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
High Throughput Protein-Protein Interaction Interrogation in Cancer
-
批准号:8470586
-
项目类别:
-
资助金额:$80.85万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
High Throughput Protein-Protein Interaction Interrogation in Cancer
-
批准号:8323746
-
项目类别:
-
资助金额:$82.6万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM
-
批准号:8512132
-
项目类别:
-
资助金额:$2.42万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
海外基金